Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
Clinical trial NCT02347176 · COMPLETED
Trial details
- NCT number
- NCT02347176
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-23
- Primary completion
- 2015-11-27
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.